These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 36056999)

  • 1. Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity.
    Menesy A; Hammad M; Aref S; Abozeid FAM
    BMC Gastroenterol; 2024 Apr; 24(1):135. PubMed ID: 38622545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.
    Jójárt B; Resál T; Kata D; Molnár T; Bacsur P; Szabó V; Varga Á; Szántó KJ; Pallagi P; Földesi I; Molnár T; Maléth J; Farkas K
    J Crohns Colitis; 2024 Mar; 18(3):392-405. PubMed ID: 37751311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon γ Expressing Mucosal Cells in Pediatric Chronic Inflammatory Bowel Disease.
    Terry J
    Pediatr Dev Pathol; 2024 Jul; ():10935266241265767. PubMed ID: 39081135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease.
    Verstockt S; Verstockt B; Machiels K; Vancamelbeke M; Ferrante M; Cleynen I; De Hertogh G; Vermeire S
    Inflamm Bowel Dis; 2021 Oct; 27(10):1564-1575. PubMed ID: 33624092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal barrier biomarkers in clinical evaluation of patients with inflammatory bowel disease.
    Mogilevski T; Nguyen AL; Ajamian M; Smith R; Rosella S; Sparrow MP; Moore GT; Gibson PR
    Eur J Gastroenterol Hepatol; 2024 Mar; 36(3):271-280. PubMed ID: 38305113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal variation of serum PCSK9 in ulcerative colitis: association with disease activity, T helper 1/2/17 cells, and clinical response of tumor necrosis factor inhibitor.
    Deng J; Jiang Y; Luan L; Fu S; Huang M; Dai Z; Liao Y; Guo S; Fu Y
    Ir J Med Sci; 2024 Feb; 193(1):165-172. PubMed ID: 37420045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Proguanylin, Pentraxin 3 and S100A12 Serum Concentrations in Diagnosis and Monitoring the Disease Activity in Crohn's Disease.
    Kałużna A; Jura-Półtorak A; Derkacz A; Olczyk K; Komosinska-Vassev K
    Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring.
    Kumar P; Vuyyuru SK; Das P; Kante B; Ranjan MK; Thomas DM; Mundhra S; Sahu P; Venigalla PM; Jain S; Goyal S; Golla R; Virmani S; Singh MK; Sachdeva K; Sharma R; Dash NR; Makharia G; Kedia S; Ahuja V
    Intest Res; 2023 Oct; 21(4):460-470. PubMed ID: 36926698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth failure in pediatric onset inflammatory bowel disease: mechanisms, epidemiology, and management.
    Ishige T
    Transl Pediatr; 2019 Jan; 8(1):16-22. PubMed ID: 30881894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?
    Wang M; Shi J; Yu C; Zhang X; Xu G; Xu Z; Ma Y
    Front Immunol; 2023; 14():1298186. PubMed ID: 38155971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches.
    Zhan Y; Jin Q; Yousif TYE; Soni M; Ren Y; Liu S
    Open Life Sci; 2023; 18(1):20220731. PubMed ID: 37808875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Fabian O; Hradsky O; Drskova T; Mikus F; Zamecnik J; Bronsky J
    Dig Dis Sci; 2018 Jul; 63(7):1811-1818. PubMed ID: 29541900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
    Boon GJ; Day AS; Mulder CJ; Gearry RB
    World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring?
    Fabian O; Klocperk A; Lerchova T; Jencova P; Stolova L; Belhajova M; Voriskova D; Kazeka D; Vicha A; Hradsky O; Bronsky J
    Dig Dis Sci; 2023 Feb; 68(2):460-470. PubMed ID: 36056999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.